Cencora Basic Shares Outstanding 2010-2025 | COR
Cencora annual/quarterly basic shares outstanding history and growth rate from 2010 to 2025. Basic shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares.
- Cencora basic shares outstanding for the quarter ending March 31, 2025 were $0.194B, a 2.81% decline year-over-year.
- Cencora basic shares outstanding for the twelve months ending March 31, 2025 were $0.784B, a 2.49% decline year-over-year.
- Cencora annual basic shares outstanding for 2024 were $0.199B, a 1.98% decline from 2023.
- Cencora annual basic shares outstanding for 2023 were $0.203B, a 2.86% decline from 2022.
- Cencora annual basic shares outstanding for 2022 were $0.208B, a 1.24% increase from 2021.
| Cencora Annual Basic Shares Outstanding (Millions of US $) |
|
|---|---|
| 2024 | $199 |
| 2023 | $203 |
| 2022 | $208 |
| 2021 | $206 |
| 2020 | $205 |
| 2019 | $210 |
| 2018 | $218 |
| 2017 | $218 |
| 2016 | $212 |
| 2015 | $218 |
| 2014 | $227 |
| 2013 | $231 |
| 2012 | $253 |
| 2011 | $272 |
| 2010 | $282 |
| 2009 | $301 |
| Cencora Quarterly Basic Shares Outstanding (Millions of US $) |
|
|---|---|
| 2025-03-31 | $194 |
| 2024-12-31 | $194 |
| 2024-09-30 | $199 |
| 2024-06-30 | $198 |
| 2024-03-31 | $199 |
| 2023-12-31 | $200 |
| 2023-09-30 | $203 |
| 2023-06-30 | $202 |
| 2023-03-31 | $202 |
| 2022-12-31 | $204 |
| 2022-09-30 | $208 |
| 2022-06-30 | $209 |
| 2022-03-31 | $209 |
| 2021-12-31 | $209 |
| 2021-09-30 | $206 |
| 2021-06-30 | $206 |
| 2021-03-31 | $205 |
| 2020-12-31 | $205 |
| 2020-09-30 | $205 |
| 2020-06-30 | $204 |
| 2020-03-31 | $205 |
| 2019-12-31 | $206 |
| 2019-09-30 | $210 |
| 2019-06-30 | $210 |
| 2019-03-31 | $211 |
| 2018-12-31 | $212 |
| 2018-09-30 | $218 |
| 2018-06-30 | $219 |
| 2018-03-31 | $219 |
| 2017-12-31 | $218 |
| 2017-09-30 | $218 |
| 2017-06-30 | $219 |
| 2017-03-31 | $218 |
| 2016-12-31 | $219 |
| 2016-09-30 | $212 |
| 2016-06-30 | $216 |
| 2016-03-31 | $208 |
| 2015-12-31 | $206 |
| 2015-09-30 | $218 |
| 2015-06-30 | $219 |
| 2015-03-31 | $220 |
| 2014-12-31 | $219 |
| 2014-09-30 | $227 |
| 2014-06-30 | $226 |
| 2014-03-31 | $229 |
| 2013-12-31 | $230 |
| 2013-09-30 | $231 |
| 2013-06-30 | $231 |
| 2013-03-31 | $230 |
| 2012-12-31 | $232 |
| 2012-09-30 | $253 |
| 2012-06-30 | $252 |
| 2012-03-31 | $258 |
| 2011-12-31 | $258 |
| 2011-09-30 | $272 |
| 2011-06-30 | $273 |
| 2011-03-31 | $274 |
| 2010-12-31 | $276 |
| 2010-09-30 | $282 |
| 2010-06-30 | $281 |
| 2010-03-31 | $282 |
| 2009-12-31 | $287 |
| 2009-09-30 | $301 |
| 2009-06-30 | $298 |
| 2009-03-31 | $302 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $56.251B | $293.959B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $140.350B | 26.32 |
| Elevance Health (ELV) | United States | $91.117B | 11.76 |
| CVS Health (CVS) | United States | $79.102B | 9.83 |
| DiDi Global (DIDIY) | China | $21.979B | 33.36 |
| Natera (NTRA) | United States | $20.836B | 0.00 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| Solventum (SOLV) | United States | $12.822B | 13.57 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.604B | 0.00 |
| CochLear (CHEOY) | Australia | $11.282B | 0.00 |
| Revvity (RVTY) | United States | $10.993B | 18.92 |
| ICON (ICLR) | Ireland | $10.630B | 9.88 |
| Viatris (VTRS) | United States | $10.375B | 3.56 |
| Doximity (DOCS) | United States | $9.813B | 45.70 |
| Avantor (AVTR) | United States | $9.138B | 13.28 |
| Medpace Holdings (MEDP) | United States | $8.785B | 23.33 |
| HealthEquity (HQY) | United States | $8.497B | 41.80 |
| Sonic Healthcare (SKHHY) | Australia | $8.220B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.924B | 13.57 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $4.257B | 39.40 |
| Bausch + Lomb (BLCO) | Canada | $4.156B | 24.50 |
| Sotera Health (SHC) | United States | $3.633B | 20.65 |
| Alignment Healthcare (ALHC) | United States | $3.122B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.068B | 39.90 |
| Concentras Parent (CON) | United States | $2.912B | 16.83 |
| Organon (OGN) | United States | $2.350B | 2.50 |
| Ardent Health Partners (ARDT) | United States | $2.204B | 9.40 |
| GeneDx Holdings (WGS) | United States | $1.949B | 75.07 |
| Progyny (PGNY) | United States | $1.912B | 42.08 |
| Premier (PINC) | United States | $1.904B | 14.45 |
| PACS (PACS) | United States | $1.647B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.414B | 28.29 |
| Teladoc Health (TDOC) | United States | $1.319B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.283B | 9.76 |
| Establishment Labs Holdings (ESTA) | $1.046B | 0.00 | |
| Agilon Health (AGL) | United States | $1.014B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.977B | 15.25 |
| Nutex Health (NUTX) | United States | $0.972B | 14.69 |
| AMN Healthcare Services Inc (AMN) | United States | $0.869B | 8.13 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.702B | 4.73 |
| InnovAge Holding (INNV) | United States | $0.566B | 0.00 |
| Enhabit (EHAB) | United States | $0.539B | 44.33 |
| Auna S.A (AUNA) | Luxembourg | $0.514B | 13.63 |
| Sonida Senior Living (SNDA) | United States | $0.494B | 0.00 |
| LifeMD (LFMD) | United States | $0.487B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.370B | 0.00 |
| SBC Medicals (SBC) | United States | $0.352B | 0.00 |
| Oncology Institute (TOI) | United States | $0.226B | 0.00 |
| Beauty Health (SKIN) | United States | $0.218B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.209B | 0.00 |
| DocGo (DCGO) | United States | $0.150B | 24.50 |
| Sera Prognostics (SERA) | United States | $0.087B | 0.00 |
| So-Young (SY) | China | $0.084B | 0.00 |
| OncoCyte (OCX) | United States | $0.080B | 0.00 |
| KindlyMD (KDLY) | United States | $0.078B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.065B | 0.00 |
| NeueHealth (NEUE) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| Biodesix (BDSX) | United States | $0.044B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.044B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.036B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.033B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |